XIANG ALAN XIN,WEBBER STEPHEN E,HALEY GREGORY J,LENNOX JOSEPH R
申请号：
IN5275/KOLNP/2008
公开号：
IN283655B
申请日:
2008.12.26
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The invention is directed to 5-amino-3-(3-deoxy--D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione prodrugs, whose metabolized parent compound has immunomodulatory activity. The invention also relates to the therapeutic use of such prodrugs and pharmaceutical compositions thereof in treating disease states associated with abnormal cell growth, such as cancer.
